References
- Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 2005;115:485–91
- Teh WT, Teede HJ, Paul E, et al. Risk factors for gestational diabetes mellitus: implications for the application of screening guidelines. Aus N Z J Obstet Gynaecol 2011;51:26–30
- Ryan EA. Diagnosing gestational diabetes. Diabetologia 2011;54:480–6
- The HAPO Study Cooperative research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009;58:453–9
- Larner J, Brautigan DL, Thorner MO. d-Chiro-inositol glycans in insulin signaling and insulin resistance. Mol Med 2010;16:543–51
- Corrado F, D’Anna R, Di Vieste G, et al. The effect of myo-inositol supplementation on insulin resistance in patients with gestational diabetes. Diabet Med 2011;28:972–5
- D’Anna R, Di Benedetto V, Rizzo P, et al. Myo-inositol may prevent gestational diabetes in PCOS women. Gynecol Endocrinol 2011;28:440–2
- Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 Explanation and Elaboration: updated guideline for reporting parallel group randomised trials. BMJ 2010;340:c869
- Conferenza Nazionale di Consenso per Raccomandazioni ed implementazione delle nuove linee guida per lo screening e la diagnosi del diabete gestazionale (GDM). Nuove linee guida per lo screening e la diagnosi del diabete gestazionale (GDM). Available from: http://www.enzasansone.it/download/diabete_gestazionale.pdf 2010
- American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008;31:S55–60
- Rutheford SE, Phelan JP, Smith CV, Jacobs N. The four-quadrant assessment of amniotic fluid volume: an adjunct to antepartum fetal heart rate testing. Obstet Gynecol 1987;70:353–6
- Paladini D, Rustico M, Viora E, et al. Fetal size charts for the Italian population: normative curves of head, abdomen and long bones. Prenat Diagn 2005;25:456–64
- Festini F, Procopio E, Taccetti G, et al. Birth weight for gestational age centiles for italian neonates. J Matern Fetal Neonatal Med 2004;15:411–17
- Baillargeon JP, Iuorno MJ, Apridonidze T, Nestler JE. Uncoupling between insulin and release of a d-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women with polycystic ovary syndrome. Metab Syndr Relat Disord 2010;8:127–36
- Nestler E, Jakubowicz DJ, Reamer P, et al. Ovulatory and metabolic effects of d-chiro-inositol in the polycystic ovary syndrome. N Engl J Med 1999;340:1314–20
- Saltier AR. Second messenger of insulin action. Diabetes Care 1990;13:244–56
- HAPO Study Cooperative research Group, Metzger BE, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991–2002
- La Delegazione SID-AMD, Di Benedetto A, Bonomo M, Di Cianni G, Mannino D, Lapolla A. Raccomandazioni per lo screening e diagnosi del diabete gestazionale. Available from: http://www.siditalia.it/in-primo-piano/436-aggiornamento-alle-raccomandazioni-per-lo-screening-e-diagnosi-del-diabete-gestazionale.html 2011
- Wier LM, Witt E, Burgess J, Elixhauser A. Hospitalizations related to diabetes in pregnancy, 2008: Statistical Brief #102. In: Healthcare Cost and Utilization Project (HCUP) statistical brief. Available from: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb102.pdf [last accessed date 2008]
- Corrado F, D’Anna R, Cannata ML, et al. Correspondence between first-trimester fasting glycaemia, and oral glucose tolerance test in gestational diabetes diagnosis. Diabetes Metab 2012;38:458--61